BIOMAT Database Logo BIOMAT Database Logo

[Type 2 diabetes: Which long-acting insulin should be preferred?]. 2012

Michael Nauck

UI MeSH Term Description Entries

Related Publications

Michael Nauck
Which basal insulin should be used in patients with type 2 diabetes mellitus?
October 2007, Current diabetes reports,
Michael Nauck
How long should a long acting insulin analogue be?
May 2013, Diabetes research and clinical practice,
Michael Nauck
Intermediate acting insulin for type 2 diabetes.
March 1985, Lancet (London, England),
Michael Nauck
Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.
April 2007, The Cochrane database of systematic reviews,
Michael Nauck
Insulin therapy in type 2 diabetes: role of the long-acting insulin glargine analogue.
June 2004, European journal of clinical investigation,
Michael Nauck
Duration of first prescribed long acting insulin therapy in type 2 diabetes.
July 2012, Diabetes research and clinical practice,
Michael Nauck
Which type 2 diabetes mellitus patients should be screened for subclinical Cushing's syndrome?
January 2017, Hormones (Athens, Greece),
Michael Nauck
Intermediate acting versus long acting insulin for type 1 diabetes mellitus.
July 2008, The Cochrane database of systematic reviews,
Michael Nauck
Choice of long-acting insulin therapy for type 2 diabetes: how can treatment for older people be optimized?
December 2011, Drugs & aging,
Michael Nauck
Treatment of type 1 and type 2 diabetes mellitus with insulin detemir, a long-acting insulin analog.
January 2010, Clinical medicine insights. Endocrinology and diabetes,
Copied contents to your clipboard!